Last updated on September 2018

A Study of S5G4T-1 in the Treatment of Papular-Pustular Rosacea


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Rosacea
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Patient must sign an Institutional Review Board (IRB) approved written informed consent for this study.
  2. Male and female 18 years of age and older.
  3. Patients must have clinical diagnosis of moderate to severe rosacea.
  4. Have a minimum total of 15.
  5. Have two nodules or less .

Exclusion Criteria:

  1. Females, who are pregnant, breastfeeding, or planning a pregnancy within the period of their study participation or were found to have positive pregnancy test at baseline or screening visits.
  2. Presence of more than 2 facial nodules or any nodule greater than 1 cm.
  3. Current or past ocular rosacea (e.g., conjunctivitis, blepharitis, or keratitis) of sufficient severity to require topical or systemic antibiotics.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.